This new post by Claire Laporte of Foley Hoag LLP appears on the Health Affairs Blog, as part of a series stemming from the Third Annual Health Law Year in P/Review event held at Harvard Law School on Friday, January 30, 2015. Do patents nurture or stifle innovation? In a recent series of decisions, the Supreme Court has begun to…
2015 Broad Institute Innovation & Intellectual Property Symposium Monday, April 13, 2015 – Wednesday, April 15, 2015 Broad Institute, 415 Main St., Cambridge, MA This symposium will bring together Broad scientists, delegates from the European and U.S. Patent Offices, and global business and legal thought leaders for discussion and information exchange on topics related to…
By Timo Minssen I am happy to announce the following publications: 1) Minssen, Timo and Nordberg, A., The Evolution of the CJEU’s Case Law on Stem Cell Patents: Context, Outcome and Implications of Case C‑364/13 International Stem Cell Corporation (March 11, 2015). Available at SSRN: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2576807 (under review for journal publication)Abstract: On 18th December 2014, the CJEU…
HLS Health Law Workshop: Amy Kapczynski February 23, 2015 5:00 PMGriswold Hall, Room 110 (Harvard Law School)1525 Massachusetts Ave., Cambridge, MA [Map here.] Professor Kapczynski’s presentation, “Order Without Intellectual Property Law: The Flu Network as a Case Study in Open Science,” is available upon request. Please contact Jennifer Minnich (jminnich@law.harvard.edu) if you would like a copy. Amy Kapczynski is an Associate Professor…
On 26th November 2013, the Danish Agency for Science, Technology and Innovation organized an expert meeting on “Synthetic Biology & Intellectual Property Rights” in Copenhagen sponsored by the European Research Area Network in Synthetic Biology (ERASynBio). The meeting brought together ten experts from different countries with a variety of professional backgrounds to discuss emerging challenges…
By Kevin Outterson This new post by Kevin Outterson appears on the Health Affairs Blog, as part of part of a series stemming from the Third Annual Health Law Year in P/Review event held at Harvard Law School on Friday, January 30, 2015. Dame Sally Davies, the Chief Medical Officer of England, warns that we are approaching an…
By Timo Minssen I am pleased to announce two new publications on (1) “European patent strategies under the UPCA” and (2) “Synthetic Biology & Intellectual Property Rights”: 1) Minssen, T & Lundqvist, B 2014, ‘The ”opt out” and “opt-in” provisions in the Unified Patent Court Agreement – Impact and strategies for European patent portfolios‘ ,…
By Rachel Sachs Who has standing to challenge a patent’s validity? And under what circumstances can Congress define an injury for the purpose of creating Article III standing? Those questions underlie a new petition for certiorari filed by Consumer Watchdog, who is asking the Supreme Court to reverse a Federal Circuit opinion holding that Consumer…
By Timo Minssen The current Ebola outbreak already attracted much attention on “Bill of Health” resulting in some excellent blogs on a horrible topic. While it is evident that the current health crisis requires both immediate responses and more sustainable changes in health care policy, research and regulation, medicines regulators are collaborating internationally to find innovative…
Legal and Ethical Issues in Healthcare Start-Ups Monday, October 6, 2014 4:00 PM Harvard Law School LOCATION CHANGE: Wasserstein Hall, Milstein West AB 1585 Massachusetts Ave. Cambridge, MA 02138 The full list of panelists is available on our website here. New healthcare start-ups face a range of legal and ethical challenges as they develop new products and services…
